Speaker:
Anya Gupta, VP Business Development, Sonde Health
Leveraging over 1 million voice samples from 80,000+ individuals, Sonde Health’s proprietary voice-based technology platform detects changes in user health - like mental fitness and respiratory disease - from changes in voice. Using advanced audio signal processing and machine learning, Sonde senses and analyzes subtle vocal changes due to changes in a person’s physiology to provide early health detection and monitoring. Sonde One, its health screening app, helps large organizations to execute a daily population screening regimen that helps reduce the spread of COVID-19, comply with government mandates, and return to work safely. Sonde has also leveraged its SurveyLex platform to enable rapid voice data collection for large clinical research organizations like UCB Pharma, Biogen, Massachusetts General Hospital, Beth Israel Deaconess Medical Center, Pear Therapeutics etc. and thereafter also enable voice-based health-detection models. Anya Gupta, Sonde's VP of Business Development, will describe the process Sonde has used since inception to develop their vocal biomarker platform.
Upcoming Events: [ Ссылка ]
All presentations from our past events on-demand: [ Ссылка ]
